Osaka, Japan

Naoya Imagawa

This inventor holds 1 USPTO granted patent. Top assignee: Noboru Kaneko. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoya Imagawa. Retrieved from https://idiyas.com/inventor/naoya-imagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Naoya Imagawa

Introduction

Naoya Imagawa is a notable inventor based in Osaka, Japan, with significant contributions to the field of medicinal chemistry. His work primarily focuses on the development of treatments for atrial fibrillation, showcasing his dedication to advancing healthcare through innovation.

Latest Patents

Imagawa holds one patent titled "Medicinal compositions for treatment of atrial fibrillation." This invention is critical for improving the quality of life for patients suffering from this common heart condition. His patent reflects his commitment to addressing pressing medical challenges through innovative solutions.

Career Highlights

Naoya Imagawa works for Noboru Kaneko, where he has been instrumental in researching and developing therapeutic solutions. His efforts in the company have positioned him as a key contributor to the company’s initiatives in enhancing medical treatments, highlighting his role as an essential member of the innovative team.

Collaborations

Throughout his career, Imagawa has collaborated with talented individuals, including Kazuo Aisaka and Hisato Miyai. These partnerships have fostered a creative environment that encourages the sharing of ideas and expertise, leading to advancements in their respective fields.

Conclusion

Naoya Imagawa exemplifies the spirit of innovation through his patent and collaborations. His contributions to medicinal compositions for treating atrial fibrillation underscore his vital role in improving healthcare solutions. With a strong foundation in research and development, Imagawa continues to impact the medical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…